Held G - Search Results

1

The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas.

Murawski N, Held G, Ziepert M, Kempf B, Viardot A, Hänel M, Witzens-Harig M, Mahlberg R, Rübe C, Fleckenstein J, Zwick C, Glass B, Schmitz N, Zeynalova S, Pfreundschuh M. Murawski N, et al. Among authors: held g. Blood. 2014 Jul 31;124(5):720-8. doi: 10.1182/blood-2013-10-535021. Epub 2014 Jun 17. Blood. 2014. PMID: 24939657 Free article. Clinical Trial.

2

Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model.

Renner C, Bauer S, Sahin U, Jung W, van Lier R, Jacobs G, Held G, Pfreundschuh M. Renner C, et al. Among authors: held g. Blood. 1996 Apr 1;87(7):2930-7. Blood. 1996. PMID: 8639913 Free article.

3

T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.

Renner C, Ohnesorge S, Held G, Bauer S, Jung W, Pfitzenmeier JP, Pfreundschuh M. Renner C, et al. Among authors: held g. Blood. 1996 Jul 1;88(1):236-41. Blood. 1996. PMID: 8704179 Free article.

4

Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivo.

Bauer S, Renner C, Juwana JP, Held G, Ohnesorge S, Gerlach K, Pfreundschuh M. Bauer S, et al. Among authors: held g. Cancer Res. 1999 Apr 15;59(8):1961-5. Cancer Res. 1999. PMID: 10213507

5

Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines.

Hartmann F, Renner C, Jung W, da Costa L, Tembrink S, Held G, Sek A, König J, Bauer S, Kloft M, Pfreundschuh M. Hartmann F, et al. Among authors: held g. Clin Cancer Res. 2001 Jul;7(7):1873-81. Clin Cancer Res. 2001. PMID: 11448899 Clinical Trial.

6

Rituximab for the treatment of diffuse large B-cell lymphomas.

Held G, Pöschel V, Pfreundschuh M. Held G, et al. Expert Rev Anticancer Ther. 2006 Aug;6(8):1175-86. doi: 10.1586/14737140.6.8.1175. Expert Rev Anticancer Ther. 2006. PMID: 16925484 Review.

7

Dose-intensified treatment of advanced-stage diffuse large B-cell lymphomas.

Held G, Schubert J, Reiser M, Pfreundschuh M; German High-Grade Non-Hodgkin-Lymphoma Study Group. Held G, et al. Semin Hematol. 2006 Oct;43(4):221-9. doi: 10.1053/j.seminhematol.2006.07.003. Semin Hematol. 2006. PMID: 17027656 Review.

8

Identification of antigenic targets of paraproteins by expression cloning does not support a causal role of chronic antigenic stimulation in the pathogenesis of multiple myeloma and MGUS.

Preuss KD, Held G, Kubuschok B, Hung CZ, Malatsidze N, Wagner M, Pfreundschuh M. Preuss KD, et al. Among authors: held g. Int J Cancer. 2007 Jul 15;121(2):459-61. doi: 10.1002/ijc.22686. Int J Cancer. 2007. PMID: 17373665 Free article.

9

MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.

Held G, Wadle A, Dauth N, Stewart-Jones G, Sturm C, Thiel M, Zwick C, Dieckmann D, Schuler G, Hoogenboom HR, Lévy F, Cerundolo V, Pfreundschuh M, Renner C. Held G, et al. Eur J Immunol. 2007 Jul;37(7):2008-17. doi: 10.1002/eji.200636545. Eur J Immunol. 2007. PMID: 17559180 Free article.

10

[Treatment of hematological malignancies with monoclonal antibodies].

Held G, Schubert J, Pfreundschuh M. Held G, et al. Internist (Berl). 2008 Aug;49(8):929-30, 932-4, 936-7. doi: 10.1007/s00108-008-2057-4. Internist (Berl). 2008. PMID: 18604513 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters